Harrison Michelle L, Dickson Benjamin F R, Sharland Mike, Williams Phoebe C M
From the School of Public Health, Faculty of Medicine, University of Sydney, Sydney, Australia.
Sydney Infectious Diseases Institute, The University of Sydney, Australia.
Pediatr Infect Dis J. 2024 Sep 12;43(12):1182-90. doi: 10.1097/INF.0000000000004485.
Sepsis remains a leading cause of neonatal mortality, particularly in low- and lower-middle-income countries (LLMIC). In the context of rising antimicrobial resistance, the etiology of neonatal sepsis is evolving, potentially making currently-recommended empirical treatment guidelines less effective. We performed a systematic review and meta-analysis to evaluate the contemporary bacterial pathogens responsible for early-onset sepsis (EOS) and late-onset neonatal sepsis (LOS) to ascertain if historical classifications-that guide empirical therapy recommendations based on assumptions around causative pathogens-may be outdated. We analyzed 48 articles incorporating 757,427 blood and cerebrospinal fluid samples collected from 311,359 neonates across 25 countries, to evaluate 4347 significant bacteria in a random-effects meta-analysis. This revealed gram-negative bacteria were now the predominant cause of both EOS (53%, 2301/4347) and LOS (71%, 2765/3894) globally. In LLMICs, the predominant cause of EOS was Klebsiella spp. (31.7%, 95% CI: 24.1-39.7%) followed by Staphylococcus aureus (17.5%, 95% CI: 8.5 to 28.4%), in marked contrast to the Streptococcus agalactiae burden seen in high-income healthcare settings. Our results reveal clear evidence that the current definitions of EOS and LOS sepsis are outdated, particularly in LLMICs. These outdated definitions may be guiding inappropriate empirical antibiotic prescribing that inadequately covers the causative pathogens responsible for neonatal sepsis globally. Harmonizing sepsis definitions across neonates, children and adults will enable a more acurate comparison of the epidemiology of sepsis in each age group and will enhance knowledge regarding the true morbidity and mortality burden of neonatal sepsis.
脓毒症仍然是新生儿死亡的主要原因,在低收入和中低收入国家(LLMIC)尤其如此。在抗菌药物耐药性不断上升的背景下,新生儿脓毒症的病因正在演变,这可能会使目前推荐的经验性治疗指南效果降低。我们进行了一项系统综述和荟萃分析,以评估导致早发型脓毒症(EOS)和晚发型新生儿脓毒症(LOS)的当代细菌病原体,以确定基于对致病病原体假设来指导经验性治疗建议的历史分类是否可能过时。我们分析了48篇文章,这些文章纳入了来自25个国家的311359名新生儿的757427份血液和脑脊液样本,在随机效应荟萃分析中评估了4347种重要细菌。这表明革兰氏阴性菌目前是全球EOS(53%,2301/4347)和LOS(71%,2765/3894)的主要病因。在LLMICs中,EOS的主要病因是克雷伯菌属(31.7%,95%CI:24.1-39.7%),其次是金黄色葡萄球菌(17.5%,95%CI:8.5至28.4%),这与高收入医疗环境中所见的无乳链球菌负担形成鲜明对比。我们的结果清楚地表明,EOS和LOS脓毒症的当前定义已经过时,特别是在LLMICs中。这些过时的定义可能导致经验性抗生素处方不当,无法充分涵盖全球新生儿脓毒症的致病病原体。统一新生儿、儿童和成人的脓毒症定义将使各年龄组脓毒症的流行病学比较更加准确,并将增强对新生儿脓毒症真正发病率和死亡率负担的认识。